Click for best price
Advanced Prostate Cancer Drug Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Advanced Prostate Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Prostate Cancer Drug. This report contains market size and forecasts of Advanced Prostate Cancer Drug in global, including the following market information:
The global Advanced Prostate Cancer Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Advanced Prostate Cancer Drug include Pfizer, Astellas, Janssen, AstraZeneca, Bayer, Hengrui, CTTQ, Sanofi and Hansoh, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Advanced Prostate Cancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Advanced Prostate Cancer Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Advanced Prostate Cancer Drug Market Segment Percentages, by Type, 2022 (%)
- Oral
- Intravenous Injection
- Others
Global Advanced Prostate Cancer Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Advanced Prostate Cancer Drug Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Specialty Clinic
- Others
Global Advanced Prostate Cancer Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Advanced Prostate Cancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Advanced Prostate Cancer Drug revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Advanced Prostate Cancer Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Astellas
- Janssen
- AstraZeneca
- Bayer
- Hengrui
- CTTQ
- Sanofi
- Hansoh
- Clovis Oncology
- Zhendong Pharmaceutical
- Merck
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Advanced Prostate Cancer Drug, market overview.
- Chapter 2: Global Advanced Prostate Cancer Drug market size in revenue.
- Chapter 3: Detailed analysis of Advanced Prostate Cancer Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Advanced Prostate Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Advanced Prostate Cancer Drug Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Advanced Prostate Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Advanced Prostate Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Advanced Prostate Cancer Drug Overall Market Size
2.1 Global Advanced Prostate Cancer Drug Market Size: 2022 VS 2029
2.2 Global Advanced Prostate Cancer Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Advanced Prostate Cancer Drug Players in Global Market
3.2 Top Global Advanced Prostate Cancer Drug Companies Ranked by Revenue
3.3 Global Advanced Prostate Cancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Advanced Prostate Cancer Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Advanced Prostate Cancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Advanced Prostate Cancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Advanced Prostate Cancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Advanced Prostate Cancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Advanced Prostate Cancer Drug Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Intravenous Injection
4.1.4 Others
4.2 By Type - Global Advanced Prostate Cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Advanced Prostate Cancer Drug Revenue, 2018-2023
4.2.2 By Type - Global Advanced Prostate Cancer Drug Revenue, 2024-2029
4.2.3 By Type - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Advanced Prostate Cancer Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application - Global Advanced Prostate Cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Advanced Prostate Cancer Drug Revenue, 2018-2023
5.2.2 By Application - Global Advanced Prostate Cancer Drug Revenue, 2024-2029
5.2.3 By Application - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Advanced Prostate Cancer Drug Market Size, 2022 & 2029
6.2 By Region - Global Advanced Prostate Cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Advanced Prostate Cancer Drug Revenue, 2018-2023
6.2.2 By Region - Global Advanced Prostate Cancer Drug Revenue, 2024-2029
6.2.3 By Region - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Advanced Prostate Cancer Drug Revenue, 2018-2029
6.3.2 US Advanced Prostate Cancer Drug Market Size, 2018-2029
6.3.3 Canada Advanced Prostate Cancer Drug Market Size, 2018-2029
6.3.4 Mexico Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Advanced Prostate Cancer Drug Revenue, 2018-2029
6.4.2 Germany Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.3 France Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.4 U.K. Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.5 Italy Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.6 Russia Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.7 Nordic Countries Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.8 Benelux Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Advanced Prostate Cancer Drug Revenue, 2018-2029
6.5.2 China Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.3 Japan Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.4 South Korea Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.5 Southeast Asia Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.6 India Advanced Prostate Cancer Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Advanced Prostate Cancer Drug Revenue, 2018-2029
6.6.2 Brazil Advanced Prostate Cancer Drug Market Size, 2018-2029
6.6.3 Argentina Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue, 2018-2029
6.7.2 Turkey Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7.3 Israel Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7.5 UAE Advanced Prostate Cancer Drug Market Size, 2018-2029
7 Advanced Prostate Cancer Drug Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Advanced Prostate Cancer Drug Major Product Offerings
7.1.4 Pfizer Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Astellas
7.2.1 Astellas Company Summary
7.2.2 Astellas Business Overview
7.2.3 Astellas Advanced Prostate Cancer Drug Major Product Offerings
7.2.4 Astellas Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.2.5 Astellas Key News & Latest Developments
7.3 Janssen
7.3.1 Janssen Company Summary
7.3.2 Janssen Business Overview
7.3.3 Janssen Advanced Prostate Cancer Drug Major Product Offerings
7.3.4 Janssen Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.3.5 Janssen Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Advanced Prostate Cancer Drug Major Product Offerings
7.4.4 AstraZeneca Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Advanced Prostate Cancer Drug Major Product Offerings
7.5.4 Bayer Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Hengrui
7.6.1 Hengrui Company Summary
7.6.2 Hengrui Business Overview
7.6.3 Hengrui Advanced Prostate Cancer Drug Major Product Offerings
7.6.4 Hengrui Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.6.5 Hengrui Key News & Latest Developments
7.7 CTTQ
7.7.1 CTTQ Company Summary
7.7.2 CTTQ Business Overview
7.7.3 CTTQ Advanced Prostate Cancer Drug Major Product Offerings
7.7.4 CTTQ Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.7.5 CTTQ Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Advanced Prostate Cancer Drug Major Product Offerings
7.8.4 Sanofi Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Hansoh
7.9.1 Hansoh Company Summary
7.9.2 Hansoh Business Overview
7.9.3 Hansoh Advanced Prostate Cancer Drug Major Product Offerings
7.9.4 Hansoh Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.9.5 Hansoh Key News & Latest Developments
7.10 Clovis Oncology
7.10.1 Clovis Oncology Company Summary
7.10.2 Clovis Oncology Business Overview
7.10.3 Clovis Oncology Advanced Prostate Cancer Drug Major Product Offerings
7.10.4 Clovis Oncology Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.10.5 Clovis Oncology Key News & Latest Developments
7.11 Zhendong Pharmaceutical
7.11.1 Zhendong Pharmaceutical Company Summary
7.11.2 Zhendong Pharmaceutical Business Overview
7.11.3 Zhendong Pharmaceutical Advanced Prostate Cancer Drug Major Product Offerings
7.11.4 Zhendong Pharmaceutical Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.11.5 Zhendong Pharmaceutical Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Advanced Prostate Cancer Drug Major Product Offerings
7.12.4 Merck Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Advanced Prostate Cancer Drug Market Opportunities & Trends in Global Market
Table 2. Advanced Prostate Cancer Drug Market Drivers in Global Market
Table 3. Advanced Prostate Cancer Drug Market Restraints in Global Market
Table 4. Key Players of Advanced Prostate Cancer Drug in Global Market
Table 5. Top Advanced Prostate Cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Advanced Prostate Cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Advanced Prostate Cancer Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Advanced Prostate Cancer Drug Product Type
Table 9. List of Global Tier 1 Advanced Prostate Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Advanced Prostate Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Advanced Prostate Cancer Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Advanced Prostate Cancer Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Advanced Prostate Cancer Drug Product Offerings
Table 32. Pfizer Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Astellas Company Summary
Table 35. Astellas Advanced Prostate Cancer Drug Product Offerings
Table 36. Astellas Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Key News & Latest Developments
Table 38. Janssen Company Summary
Table 39. Janssen Advanced Prostate Cancer Drug Product Offerings
Table 40. Janssen Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Janssen Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Advanced Prostate Cancer Drug Product Offerings
Table 44. AstraZeneca Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Advanced Prostate Cancer Drug Product Offerings
Table 48. Bayer Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Hengrui Company Summary
Table 51. Hengrui Advanced Prostate Cancer Drug Product Offerings
Table 52. Hengrui Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Hengrui Key News & Latest Developments
Table 54. CTTQ Company Summary
Table 55. CTTQ Advanced Prostate Cancer Drug Product Offerings
Table 56. CTTQ Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 57. CTTQ Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Advanced Prostate Cancer Drug Product Offerings
Table 60. Sanofi Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Hansoh Company Summary
Table 63. Hansoh Advanced Prostate Cancer Drug Product Offerings
Table 64. Hansoh Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Hansoh Key News & Latest Developments
Table 66. Clovis Oncology Company Summary
Table 67. Clovis Oncology Advanced Prostate Cancer Drug Product Offerings
Table 68. Clovis Oncology Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Clovis Oncology Key News & Latest Developments
Table 70. Zhendong Pharmaceutical Company Summary
Table 71. Zhendong Pharmaceutical Advanced Prostate Cancer Drug Product Offerings
Table 72. Zhendong Pharmaceutical Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Zhendong Pharmaceutical Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Advanced Prostate Cancer Drug Product Offerings
Table 76. Merck Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
List of Figures
Figure 1. Advanced Prostate Cancer Drug Segment by Type in 2022
Figure 2. Advanced Prostate Cancer Drug Segment by Application in 2022
Figure 3. Global Advanced Prostate Cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Advanced Prostate Cancer Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Advanced Prostate Cancer Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Advanced Prostate Cancer Drug Revenue in 2022
Figure 8. By Type - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 16. US Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 20. Germany Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 28. China Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Janssen Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hengrui Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CTTQ Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hansoh Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Clovis Oncology Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zhendong Pharmaceutical Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
